Evaluating the Safety of BONEBRIDGE Implants in Children Under Five Years Old: This Study Looks at Children Under Five Who Got BONEBRIDGE BCI 602 Implants. It Collects Information on Any Problems With the Device or the Surgery to See if it is Safe Within the First Year After the Operation.
2023BB006
The BONEBRIDGE in Children Below Five Years of Age Premarket Clinical Investigation
2 other identifiers
observational
9
1 country
2
Brief Summary
This study, titled "The BONEBRIDGE in Children Under Five: Premarket Clinical Investigation" (Study ID 2023BB006), looks at kids under five who have received the BONEBRIDGE BCI 602 hearing implant. This observational study, which is both retrospective (looking back) and prospective (looking forward), will take place at multiple hospitals. The main goal is to see if the BONEBRIDGE implant is safe for young children within 12 months after surgery. Primary Goal: The study's main aim is to collect all information about any bad experiences or issues related to the device and the surgery to check its safety. Secondary Goals: Hearing Improvement: Using tests like the Göttinger Speech Intelligibility Test (Word Recognition Scores) to see how much the hearing improves with the implant. Treatment History: Surgeons will fill out questionnaires about how the treatment went. Quality of Life: Parents will answer questions about their child's quality of life using the GCBI questionnaire at least 12 months after the implant. The study will last up to 12 months, including enrolling participants and performing all necessary procedures. The target number of participants includes at least 12 sets of data for safety checks and at least 5 sets of hearing performance data. By collecting detailed information on any problems and assessing the performance of the BONEBRIDGE implant, this study aims to determine if it is safe and effective for young children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 25, 2024
CompletedFirst Submitted
Initial submission to the registry
October 8, 2024
CompletedFirst Posted
Study publicly available on registry
October 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 8, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 4, 2026
CompletedApril 1, 2026
March 1, 2026
1 year
October 8, 2024
March 31, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of speech intelligibility using the Göttinger Speech Intelligibility Test.
Hearing Improvement: determined by using the Göttinger Speech Intelligibility Test (Word Recognition Scores). Improvements in hearing with the BONEBRIDGE implant will be evaluated in device aided and unaided condition at least 12 months post-implantation.
Day 1
Secondary Outcomes (2)
Assessment of quality of life using the GCBI questionnaire
Day 1
Evaluation based on treatment history questionnaires for surgeons
Day 1
Interventions
Improvement in hearing using BCI.
Eligibility Criteria
Children under 5 years old with BONEBRIDGE BCI 602 implants
You may qualify if:
- Children who received the BONEBRIDGE BCI 602 implant before the age of five and have had the implant for at least 12 months.
- Ability to perform the German language test. Willingness and ability to undergo all tests required by the study. Signed and dated informed consent obtained before any study-specific procedure and collection of retrospective data.
You may not qualify if:
- Inability to perform audiological tests due to psychological, emotional, or related physical disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Medizinische Hochschule Hannover
Hanover, Lower Saxony, 30625, Germany
Universitätsklinikum Schleswig-Holstein, Klinik für Hals-, Nasen- und Ohrenheilkunde
Lübeck, Schleswig-Holstein, 23562, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 8, 2024
First Posted
October 10, 2024
Study Start
September 25, 2024
Primary Completion
October 8, 2025
Study Completion
February 4, 2026
Last Updated
April 1, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share